Table 2. Correlation between the SETD7 and clinicopatologic variables in HCC.
| SETD7 expression | ||||
|---|---|---|---|---|
| Clinical characters | Low n (%) | High n (%) | χ² | p value |
| Age (y) | 0.107 | 0.744 | ||
| ≤55 | 37 (16.4%) | 79 (35.1%) | ||
| >50 | 37 (16.4%) | 72 (32.0%) | ||
| Gender | 0.005 | 0.946 | ||
| Male | 60 (26.7%) | 123 (54.7%) | ||
| Female | 14 (6.2%) | 28 (12.4%) | ||
| Liver cirrhosis | 0.476 | 0.49 | ||
| No | 16 (7.1%) | 39 (17.3%) | ||
| Yes | 58 (25.8%) | 112 (49.8%) | ||
| AFP (ng/ml) | 0.717 | 0.397 | ||
| ≤200 | 47 (20.9%) | 87 (38.7%) | ||
| >200 | 27 (12.0%) | 64 (28.4%) | ||
| Tumor differentiation | 4.175 | 0.047 | ||
| I-II | 46 (20.4%) | 72 (32.0%) | ||
| III-IV | 28 (12.4%) | 79 (35.1%) | ||
| Tumor size (cm) | 10.762 | 0.001 | ||
| ≤5 | 51 (22.7%) | 69 (30.7%) | ||
| >5 | 23 (10.2%) | 82 (36.4%) | ||
| Tumor number | 1.494 | 0.222 | ||
| Single | 59 (26.2%) | 109 (48.4%) | ||
| Multiple | 15 (6.7%) | 42 (18.7%) | ||
| Recurrence | 6.347 | 0.012 | ||
| No | 48 (21.3%) | 71 (31.6%) | ||
| Yes | 26 (11.6%) | 80 (35.6%) | ||
| Hepatitis | 1.073 | 0.300* | ||
| No | 4 (1.8%) | 16 (7.1%) | ||
| Yes | 70 (31.1%) | 135 (60.0%) | ||
| Metastasis | 6.863 | 0.009 | ||
| No | 63 (28.0%) | 104 (46.2%) | ||
| Yes | 11 (4.9%) | 47 (20.9%) | ||
*Correction for continuity chi square test